Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Retinal Diseases × Ranibizumab × Clear all

Phase

Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 2 Retinal Diseases 1 Melanoma 1 Macular Edema 1 Glaucoma, Neovascular 1 Conjunctival Neoplasms 1

Interventions

Ranibizumab 1 Hematopoietic Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00750399 2012-04-26

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

The New York Eye Cancer Center

Phase 1 Completed

Uveal Melanoma, Melanoma, Retinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡